MDxHealth SA Files 6-K with Interim Report
Ticker: MDXH · Form: 6-K · Filed: Aug 21, 2024 · CIK: 1872529
| Field | Detail |
|---|---|
| Company | Mdxhealth SA (MDXH) |
| Form Type | 6-K |
| Filed Date | Aug 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: interim-report, foreign-private-issuer, sec-filing
TL;DR
MDxHealth SA dropped its 6-K with interim results, check it out.
AI Summary
MDxHealth SA filed a Form 6-K on August 21, 2024, reporting its 2024 Interim Report and a press release. The filing includes information for the month of August 2024 and is submitted under the 1934 Securities Exchange Act. The company is a foreign private issuer and files annual reports under Form 20-F.
Why It Matters
This filing provides investors with an update on MDxHealth SA's financial performance and operational activities for the interim period, crucial for assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of an interim report and press release, not indicating any immediate significant financial or operational changes.
Key Players & Entities
- MDxHealth SA (company) — Registrant
- August 21, 2024 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report the registrant's 2024 Interim Report and a press release issued by the Company on August 21, 2024.
What is the Commission File Number for MDxHealth SA?
The Commission File Number for MDxHealth SA is 001-40996.
Does MDxHealth SA file annual reports under Form 20-F or Form 40-F?
MDxHealth SA files annual reports under cover of Form 20-F.
What is the principal executive office address of MDxHealth SA?
The principal executive office address of MDxHealth SA is CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium.
What period does this Form 6-K report cover?
This Form 6-K report is for the month of August 2024 and includes the 2024 Interim Report.
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-08-21 16:13:41
Filing Documents
- ea0211994-6k_mdx.htm (6-K) — 14KB
- ea021199401ex4-1_mdx.htm (EX-4.1) — 31KB
- ea021199401ex4-2_mdx.htm (EX-4.2) — 42KB
- ea021199401ex99-1_mdx.htm (EX-99.1) — 330KB
- ea021199401ex99-2_mdx.htm (EX-99.2) — 88KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- ex99-2_001.jpg (GRAPHIC) — 2KB
- 0001213900-24-071457.txt ( ) — 510KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: August 21, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2